Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: The EBMT experience
- Ugo De Giorgi*
- , T. Demirer
- , H. Wandt
- , C. Taverna
- , W. Siegert
- , M. Bornhauser
- , T. Kozak
- , G. Papiani
- , M. Ballardini
- , G. Rosti
- , M. Marangolo
- , G. Ehninger
- , M. Suttorp
- , Carl Gustav Carus
- , D. Lutz
- , A. P. Schwarer
- , A. Thyss
- , H. Ludwig
- , G. Baumgartner
- , B. Lioure
*Corresponding author for this work
- Ospedale S. Maria delle Croci
- Ankara University
- Klinikum Nurnberg
- University of Zurich
- Charité – Universitätsmedizin Berlin
- Technische Universität Dresden
- Charles University
- Istituto Oncologico Romagnolo
- Krankenhaus der Elisabethinen
- Alfred Health
- Centre Antoine Lacassagne
- Klinik Ottakring
- University Hospital of Strasbourg
- University of Basel
- Hannover Medical School
- University of Liege
- University of Oldenburg
- University Hospital Southampton NHS Foundation Trust
- University Hospital
- Saint-Pierre University Hospital
- Victor Babes National Institute
- Cambridge University Hospitals NHS Foundation Trust
- St James's Hospital
- King's College London
- Linköping University
- Lund University
- Johannes Gutenberg University Mainz
- Asst Grande Ospedale Metropolitano Niguarda
- CHU Montpellier
- Children's Medical Center
- University of Rostock
- Karolinska Institutet
- Medical University of Vienna
- Donauspital
Research output: Contribution to journal › Article › peer-review
77
Scopus
citations